Paraquat, a widely-used herbicide, has been linked to Parkinsons disease, leading to numerous Paraquat Parkinsons Disease Lawsuits against its manufacturers for failing to warn about the risks of chronic exposure
In a phase 2 study, the medication showed up to 20% average weight loss at 52 weeks for people with obesity or overweight without diabetes and 17% for those with overweight/obesity and type 2 diabetes
For me, this product was never just about weight loss, Kardashian Barker tells me
Comparative outcomes of systemic diseases in people with type 2 diabetes, or obesity alone treated with and without GLP-1 receptor agonists: a retrospective cohort study from the global collaborative network
This guide is designed to fill that gap, offering clear, evidence-based strategies to help you navigate common challenges, maximize the medications benefits, and ensure your weight loss journey supports long-term health, muscle preservation, and metabolic resilience
Oncol Rep